Monitoring Hyperkalemia Using Point-of-care AI-enabled ECG Device Among Patients With Chronic Kidney Disease Stages 3b-5
A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 1066 participants.
Also called NCT06901960
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose prevention
- Phase
- Not applicable
- Enrolled
- 1,066 participants
- Registry
-
NCT06901960
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Recruiting
Technical summary
Registry record NCT06901960. Randomized; no masking; primary purpose prevention. Start 2025-04-02 (actual); primary completion 2027-12-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Monitoring Hyperkalemia Using Point-of-care AI-enabled ECG Device Among Patients With Chronic Kidney Disease Stages 3b-5
- Acronym
- Condition
- Chronic Kidney Disease (Stages 3b-5)
- Intervention (Device)
- A mobile artificial intelligence-enhanced electrocardiogram device estimating plasma potassium categories (<5 mmol/L, 5 - <5.5 mmol/L, 5.5 - <6.0 mmol/L and ≥ 6.0 mmol/L)
- Lead sponsor
- Peking University First Hospital
Record details
- Record id
cardio:ct-nct06901960- Content hash
cae9787b5256b0f64193476a2d3dbfd903e64a1a7510d9568aad7165381cfe16